Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01173042 · ClinicalTrials.gov registry record · Phase 1
Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides
A Phase 1 study, sponsored by Penn State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01173042 is a Phase 1 study that has completed, run by Penn State University. The registered enrollment target is 6 participants.
The verdict
NCT01173042, a Phase 1 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This pilot study will investigate the effects of acute peanut consumption on markers of inflammation, triglycerides and glucose. The hypothesis is that a high glucose/SFA meal will increase postprandial production of the inflammatory marker, C-reactive protein (CRP), and that the addition of peanuts to the control meal will reduce the production of CRP, as well as triglycerides and glucose.
Interventions
- DIETARY_SUPPLEMENT Peanuts
- DIETARY_SUPPLEMENT Glucose and whipping cream
- DIETARY_SUPPLEMENT Oil Blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01173042
The ClinicalTrials.gov registry entry for NCT01173042 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Peanuts is the first listed.
NCT01173042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01173042 about?
NCT01173042 is a clinical study titled "Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides". This pilot study will investigate the effects of acute peanut consumption on markers of inflammation, triglycerides and glucose. The hypothesis is that a high glucose/SFA meal will increase postprandial production of the inflammatory marker, C-reactive protein (CRP), and that the addition of peanuts...
What is the current status of trial NCT01173042?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2009-08. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01173042?
The interventions under investigation include: Peanuts (DIETARY_SUPPLEMENT), Glucose and whipping cream (DIETARY_SUPPLEMENT), Oil Blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01173042?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.